Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human IRF5 Antibodies:
anti-Mouse (Murine) IRF5 Antibodies:
anti-Rat (Rattus) IRF5 Antibodies:
Go to our pre-filtered search.
Human Polyclonal IRF5 Primary Antibody for ChIP, ELISA - ABIN249633
Barnes, Moore, Pitha: Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. in The Journal of biological chemistry 2001
Show all 8 Pubmed References
Cow (Bovine) Polyclonal IRF5 Primary Antibody for WB - ABIN2779405
Coletta, Cullington, Clark, Cleland: Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF. in European journal of heart failure 2008
Show all 2 Pubmed References
Mouse (Murine) Polyclonal IRF5 Primary Antibody for WB - ABIN2779987
Takaoka, Yanai, Kondo, Duncan, Negishi, Mizutani, Kano, Honda, Ohba, Mak, Taniguchi: Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. in Nature 2005
Mouse (Murine) Monoclonal IRF5 Primary Antibody for FACS - ABIN4327584
Li, De, Li, Song, Matta, Barnes: Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality. in Scientific reports 2016
Human Monoclonal IRF5 Primary Antibody for IHC (p), IP - ABIN2475143
Barnes, Kellum, Field, Pitha: Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. in Molecular and cellular biology 2002
Data suggest that IRAK4 (show IRAK4 Antibodies) activity regulates activation of IRF5, TAK1 (show MAP3K7 Antibodies), and IKKB (show IKBKB Antibodies) in monocytes; IRAK4 (show IRAK4 Antibodies) activation of TAK1 (show MAP3K7 Antibodies)-IKKB (show IKBKB Antibodies)-IRF5 axis leads to induction of cytokines and interferons following TLR7 (show TLR7 Antibodies)/TLR8 (show TLR8 Antibodies) stimulation. (IRAK4 (show IRAK4 Antibodies) = interleukin-1 receptor-associated kinase 4 (show IRAK4 Antibodies); IRF5 = interferon regulatory factor-5; TAK1 (show MAP3K7 Antibodies) = MAPK (show MAPK1 Antibodies) kinase kinase 7; IKKB (show IKBKB Antibodies) = I-kappa B kinase; TLR = toll (show TLR4 Antibodies)-like receptor)
IRF5 and IRF5 disease-risk variants increase glycolysis and human m1 macrophage polarization by regulating proximal signaling and Akt2 (show AKT2 Antibodies) activation.
the genomic pattern according to MATH demonstrated that mutation rates of TP53, IRF5 and KRAS were independently associated with MATH, and the latter two were only significant in male patients. As MATH increased, the fraction of somatic copy number alteration (SCNA) elevated. Moreover, more SCNA events was independently associated with MATH in male than in female
IRF-5 targeted the expression of vascular cell adhesion molecule 1 (VCAM-1 (show VCAM1 Antibodies)) at the transcriptional level by binding to its promoter.
oncogenic IRF5 overexpression in HL is the result of a specific LTR transcriptional activation
the primary activating regulatory region of human IRF5 was located in its minimal promoter region between nucleotides -179 and +62. In addition, it was shown that Sp1 (show PSG1 Antibodies) was able to bind to the multiple sites in IRF5 promoter region, and was involved in the transcriptional regulation of IRF5 at the basal level.
This study demonstrates the association of IRF5 with an increased susceptibility for systemic lupus erythematosus (SLE) in the population of Crete and emphasizes the association of the Neanderthal-derived IRF5 haplotype with SLE susceptibility. Patients carrying allele the Neanderthal allele C had greater type I IFN, supporting a functional consequence of this polymorphism.
this study shows that IRF5 polymorphisms are associated with unexplained recurrent pregnancy loss among Iranian women
The results demonstrated that STAT4 (show STAT4 Antibodies) rs7574865 and IRF5 rs2004640G/T substitution are associated with a susceptibility to systemic sclerosis.
Data suggest that interferon beta (IFN-beta (show IFNB1 Antibodies)) might be involved in modulating the expressions of interferon regulatory factor 1 (IRF1 (show IRF1 Antibodies)) and interferon regulatory factor-5 protein (IRF5) as well as maintaining the M1 polarization status and its function.
BCG (show SLC11A1 Antibodies) increased membrane expression of TRIM59 through the TLR2 (show TLR2 Antibodies)/ TLR4 (show TLR4 Antibodies)/IRF5 pathway in RAW264.7 macrophage cell line.
these results reveal a role for Lyn (show LYN Antibodies) as a specific suppressor of the TLR-MyD88 (show MYD88 Antibodies)-IRF5 pathway and illustrate the importance of fine-tuning IRF5 activity for the maintenance of immune homeostasis
IRF5 siRNA reverses pancreatitis-induced activation of lung macrophages from M1 phenotype to M2 phenotype in severe acute pancreatitis associated with acute lung injury.
Our data show that miR (show MLXIP Antibodies)-146b targets IRF5, resulting in the regulation of macrophage activation. Furthermore, miR (show MLXIP Antibodies)-146b deficient mice developed intestinal inflammation with enhanced M1 macrophage polarization.
data suggest that IRF5 plays a causal role in inflammation, fibrosis and impaired vascular EC function in Tsk (show FBN1 Antibodies)/+ mice
study sheds light on the TLR4 (show TLR4 Antibodies)-IRF5 pathway in the pathology of SSc (show CYP11A1 Antibodies) with clinical implications of targeting the IRF5 pathways in the suppression of disease development
Collectively, these results indicate a key role for IRF-5 in modulating the host antiviral response in peripheral organs that controls bunyavirus neuroinvasion in mice.
studies extend prior ones suggesting that inhibiting IRF5 might be useful for chronic macrophage-induced inflammation and suggest that IRF5 blockade would ameliorate more acute forms of inflammation, including lung injury
IRF5 plays an important role in the development of disease in the MRL/lpr (show FAS Antibodies) mouse model of lupus in the absence of the DOCK2 (show DOCK2 Antibodies) mutation and that IRF5 is required for the transition from mature B cells to plasma cells.
This gene encodes a member of the interferon regulatory factor (IRF) family, a group of transcription factors with diverse roles, including virus-mediated activation of interferon, and modulation of cell growth, differentiation, apoptosis, and immune system activity. Members of the IRF family are characterized by a conserved N-terminal DNA-binding domain containing tryptophan (W) repeats. Multiple transcript variants encoding different isoforms have been found for this gene, and a 30-nt indel polymorphism (SNP rs60344245) can result in loss of a 10-aa segment.
interferon regulatory factor 5
, Interferon regulatory factor 5
, interferon regulatory factor 5-like
, interferon regulatory factor 5 bone marrow